TCR-T immunotherapy targeting EBV-associated malignancies

被引：0
|
作者：
Jia, L. [1 ]
Chen, H. [1 ]
Liu, F. [1 ]
Wu, D. [2 ]
Ding, Z. [1 ]
Rui, W. [1 ]
Zhao, X. [1 ]
Chen, W. [2 ]
Lin, X. [1 ]
机构：
[1] Tsinghua Univ, Beijing, Peoples R China
[2] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2286
引用
收藏
页码：1722 / 1722
页数：1
相关论文
共 50 条
  • [1] Immunotherapy for EBV-associated malignancies
    Merlo, Anna
    Turrini, Riccardo
    Dolcetti, Riccardo
    Zanovello, Paola
    Rosato, Antonio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 93 (03) : 281 - 293
  • [2] Immunotherapy for EBV-associated malignancies
    Anna Merlo
    Riccardo Turrini
    Riccardo Dolcetti
    Paola Zanovello
    Antonio Rosato
    International Journal of Hematology, 2011, 93 : 281 - 293
  • [3] Targeting EBV-associated malignancies
    Sarah Crunkhorn
    Nature Reviews Drug Discovery, 2019, 18 (5) : 338 - 338
  • [4] Adoptive immunotherapy for EBV-associated malignancies
    Gottschalk, S
    Heslop, HE
    Rooney, CM
    LEUKEMIA & LYMPHOMA, 2005, 46 (01) : 1 - 10
  • [5] Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines
    Rooney, CM
    Aguilar, LK
    Huls, MH
    Brenner, MK
    Heslop, HE
    EPSTEIN-BARR VIRUS AND HUMAN CANCER, 2001, 258 : 221 - 229
  • [6] T-cell therapies for EBV-associated malignancies
    Brenner, MK
    Bollard, C
    Huls, MH
    Gottschalk, S
    Heslop, HE
    Rooney, CM
    REGENERATIVE AND CELL THERAPY: CLINICAL ADVANCES, 2005, (11): : 121 - 130
  • [7] Human cytotoxic T lymphocyte responses to Epstein-Barr virus (EBV) - Implications for immunotherapy of EBV-associated malignancies
    Gavioli, R
    MINERVA BIOTECNOLOGICA, 1999, 11 (01) : 1 - 6
  • [8] TCR-T Immunotherapy: The Challenges and Solutions
    Liu, Yating
    Yan, Xin
    Zhang, Fan
    Zhang, Xiaoxia
    Tang, Futian
    Han, Zhijian
    Li, Yumin
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [9] The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
    Lo, Angela Kwok-Fung
    Dawson, Christopher W.
    Lung, Hong Lok
    Wong, Ka-Leung
    Young, Lawrence S.
    CANCERS, 2020, 12 (07) : 1 - 12
  • [10] T cell-based therapies for EBV-associated malignancies
    Taylor, GS
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (01) : 11 - 21
12345